作者: Matthew T. Harting , Fernando Jimenez , Hasan Xue , Uwe M. Fischer , James Baumgartner
关键词:
摘要: Object Cell therapy has shown preclinical promise in the treatment of many diseases, and its application is being translated to clinical arena. Intravenous mesenchymal stem cell (MSC) been improve functional recovery after traumatic brain injury (TBI). Herein, authors report on their attempts reproduce such observations, including detailed characterizations MSC population, non–bromodeoxyuridine-based labeling, macroscopic microscopic tracking, quantification cells traversing pulmonary microvasculature, well-validated measurement motor cognitive function recovery. Methods Rat MSCs were isolated, expanded vitro, immunophenotyped, labeled. Four million intravenously infused into Sprague-Dawley rats 24 hours receiving a moderate, unilateral controlled cortical impact TBI. Infrared tracking was used identify distribution. Immunohistochemical analysis lung tissues 48 2 we...